Cioffi Luigi, Gallo Patrizia, D'Avino Antonio, Carlomagno Francesco, Aloi Giuseppe, D'Onofrio Antonietta, Del Gaizo Donatella, Giuliano Maria, De Franchis Raffaella, Sandomenico Maria L, Pecoraro Anna
FIMP (Italian Federation Pediatric Doctors), Naples, Italy.
Naples University, Naples, Italy.
Glob Pediatr Health. 2017 Sep 1;4:2333794X17725983. doi: 10.1177/2333794X17725983. eCollection 2017.
. This study, a randomized controlled trial, aims to demonstrate a clinically significant improvement in subacute and chronic otitis media with effusion through the administration of hyaluronic acid associated with hypertonic solution compared with the administration of hypertonic solution alone. The setting was an outpatient clinic of 20 primary care pediatrician offices affiliated with the 3 Local Health Units (Azienda Sanitaria Locale) of Naples. . The study was conducted for 6 months, from October 2014 to the end of March 2015. The study saw the participation of 20 pediatricians who were experts in pneumatic otoscopy, each of whom enrolled 15 children. Each investigator was randomized to carry out the treatment with 3% hypertonic solution or high-molecular-weight hyaluronic acid + 3% hypertonic solution. . A total of 275 children were enrolled, of whom 11(equal to 4% ) were lost to follow-up. A total of 264 children completed the trial according to the protocol, 120 in the hyaluronic acid + hypertonic solution group and 144 in the hypertonic solution group. Hyaluronic acid associated with hypertonic solution and hypertonic solution alone administered by nasal lavage have proven to be safe and effective in the treatment of prolonged otitis media with effusion (initial score of -0.5, final score of 0.9, < 001, for the hypertonic + hyaluronic acid group; initial score of -0.3, final score of 0.2, < .001, for the hypertonic solution group). Though starting from a less favorable initial clinical score (-0.5 vs -0.3, < .016), hyaluronic acid associated with hypertonic solution resulted in a significant increase in clinical healing (0.9 vs 0.2, < .001). One interesting outcome was the significant reduction in the consumption of drugs (cortisone and antibiotics) during the follow-up.
本研究为一项随机对照试验,旨在证明与单独使用高渗溶液相比,通过给予与高渗溶液联合使用的透明质酸,可使亚急性和慢性分泌性中耳炎在临床上出现显著改善。研究地点为那不勒斯3个地方卫生单位(Azienda Sanitaria Locale)下属的20个基层儿科医生办公室的门诊。本研究为期6个月,从2014年10月至2015年3月底。该研究有20名擅长气导耳镜检查的儿科医生参与,每位医生招募15名儿童。每位研究者被随机分配用3%高渗溶液或高分子量透明质酸+3%高渗溶液进行治疗。总共招募了275名儿童,其中11名(占4%)失访。共有264名儿童按方案完成试验,透明质酸+高渗溶液组120名,高渗溶液组144名。经鼻腔灌洗给予与高渗溶液联合使用的透明质酸和单独使用高渗溶液已被证明在治疗持续性分泌性中耳炎方面安全有效(高渗+透明质酸组初始评分为-0.5,最终评分为0.9,P<0.001;高渗溶液组初始评分为-0.3,最终评分为0.2,P<0.001)。尽管起始临床评分较低(-0.5对-0.3,P<0.016),但与高渗溶液联合使用的透明质酸导致临床治愈率显著提高(0.9对0.2,P<0.001)。一个有趣的结果是随访期间药物(皮质醇和抗生素)消耗量显著减少。